Related Experiment Video
Updated: Sep 7, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.5K
Smartphone Apps for Diabetes Medication Adherence: Systematic Review.
Sheikh Mohammed Shariful Islam1, Vinaytosh Mishra2, Muhammad Umer Siddiqui3
1Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Faculty of Health, Deakin University, Melbourne, Australia.
JMIR Diabetes
|June 21, 2022
Summary
Many free diabetes medication adherence apps show low effectiveness. This study evaluated high-quality apps, finding nearly half did not significantly improve medication adherence in patients with diabetes.
Area of Science:
- Digital health
- Mobile health (mHealth)
- Chronic disease management
Background:
- Diabetes mellitus is a global chronic disease requiring regular blood glucose monitoring and management.
- Poor medication adherence is a significant challenge for individuals with diabetes.
- Smartphone applications offer potential to improve medication adherence, but optimal features remain unclear.
Purpose of the Study:
- To systematically review and evaluate high-quality, publicly available smartphone apps for diabetes medication adherence.
- To identify beneficial app features for enhancing medication adherence in diabetes patients.
- To present the technical features of evaluated diabetes management apps.
Main Methods:
- Systematic search of Apple App Store and Google Play for diabetes medication adherence apps.
- Assessment using the Mobile App Rating Scale (MARS) and calculation of Mean App-Specific Score (MASS).
- Evaluation of apps based on a task-technology fit matrix and a quality score >4 out of 5.
Main Results:
- Eight high-quality apps (MASS score ≥4) were identified and analyzed.
- App features and physiological factors influencing diabetes were considered in the evaluation framework.
- 50% of evaluated apps demonstrated low effectiveness in promoting diabetes medication adherence, while 25% showed moderate and 25% high adherence.
Conclusions:
- A significant proportion of high-quality, free diabetes apps do not effectively promote medication adherence.
- A standardized framework is crucial for evaluating and selecting apps that enhance medication adherence.
- Future app development should focus on features proven to improve adherence for better patient outcomes.
Related Concept Videos
01:28Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
01:15Diabetes: Management and Pharmacotherapy
353
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
353
01:16Insulin: Dosing Regimen and Adverse Effects
251
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
251
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
286
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
286
01:14SBAR II: Application of SBAR
4.7K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.7K
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K